IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.292
AS - Asia 11.350
EU - Europa 10.132
SA - Sud America 1.969
AF - Africa 1.069
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 12
Totale 45.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.409
SG - Singapore 6.037
CN - Cina 3.029
RU - Federazione Russa 3.015
IE - Irlanda 1.916
UA - Ucraina 1.783
BR - Brasile 1.650
IT - Italia 1.320
VN - Vietnam 989
CA - Canada 728
FR - Francia 601
CI - Costa d'Avorio 537
KR - Corea 350
SE - Svezia 308
NG - Nigeria 292
GB - Regno Unito 214
GR - Grecia 195
IN - India 178
DE - Germania 173
BD - Bangladesh 171
NL - Olanda 133
AR - Argentina 125
HK - Hong Kong 96
FI - Finlandia 92
MX - Messico 92
IQ - Iraq 77
PL - Polonia 75
CH - Svizzera 64
SN - Senegal 64
EC - Ecuador 62
AT - Austria 59
ID - Indonesia 59
ZA - Sudafrica 58
TR - Turchia 54
UZ - Uzbekistan 53
ES - Italia 49
JP - Giappone 42
VE - Venezuela 33
PK - Pakistan 32
CO - Colombia 30
MA - Marocco 29
BE - Belgio 27
KE - Kenya 26
BJ - Benin 23
PE - Perù 19
JO - Giordania 18
PY - Paraguay 18
SA - Arabia Saudita 17
CL - Cile 16
AE - Emirati Arabi Uniti 15
EU - Europa 15
JM - Giamaica 15
PH - Filippine 15
CZ - Repubblica Ceca 14
MY - Malesia 14
LT - Lituania 13
BG - Bulgaria 12
IR - Iran 12
AL - Albania 11
AZ - Azerbaigian 11
EG - Egitto 11
LB - Libano 11
NP - Nepal 11
RO - Romania 10
UY - Uruguay 10
HN - Honduras 9
BY - Bielorussia 8
TN - Tunisia 8
CR - Costa Rica 7
IL - Israele 7
KZ - Kazakistan 7
RS - Serbia 7
DZ - Algeria 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
SI - Slovenia 6
AU - Australia 5
BH - Bahrain 5
BO - Bolivia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
GE - Georgia 3
MD - Moldavia 3
MK - Macedonia 3
PT - Portogallo 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BN - Brunei Darussalam 2
BZ - Belize 2
Totale 45.804
Salva come PNG Salva come JPEG
Città #
Singapore 3.351
Dallas 3.114
Jacksonville 2.338
Santa Clara 2.061
Dublin 1.912
San Jose 1.507
Chandler 1.364
Ashburn 1.033
Moscow 1.025
Boardman 924
Houston 639
Nanjing 637
Abidjan 537
Lawrence 534
Andover 529
Cambridge 528
Lauterbourg 509
Toronto 507
Chicago 442
Hefei 424
Catania 403
Des Moines 373
Seoul 349
Los Angeles 295
Ho Chi Minh City 271
Beijing 229
Nanchang 227
San Mateo 226
Hanoi 222
Civitanova Marche 201
Abuja 191
Wilmington 187
Hebei 172
São Paulo 156
Shenyang 151
Dong Ket 141
Athens 138
Ottawa 134
New York 132
Council Bluffs 124
Buffalo 119
Jiaxing 115
Tianjin 113
Saint Petersburg 112
Changsha 88
Lagos 86
Milan 82
Amsterdam 81
Hong Kong 81
Dakar 64
Lappeenranta 64
Washington 60
Orem 59
Rome 59
Warsaw 55
Brooklyn 53
Seattle 48
Phoenix 47
Montreal 45
Atlanta 44
Rio de Janeiro 44
Da Nang 43
Bremen 41
Norwalk 41
Hangzhou 40
Belo Horizonte 37
Denver 37
Mexico City 37
Boston 36
Stockholm 36
Redondo Beach 35
Chennai 34
Jinan 33
Johannesburg 32
Kunming 32
Tokyo 32
Pune 31
Curitiba 30
Frankfurt am Main 30
Haiphong 29
Ningbo 29
San Francisco 29
San Giovanni la Punta 29
London 28
Porto Alegre 27
Brussels 26
Helsinki 26
Columbus 25
Palermo 25
Baghdad 24
Brasília 24
Den Haag 24
Zhengzhou 24
Cotonou 23
Guayaquil 23
Liberty Lake 23
Poplar 23
The Dalles 23
Nuremberg 22
Elk Grove Village 21
Totale 30.920
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 560
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 256
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 226
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 185
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 178
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 165
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 163
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 161
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 159
[Management of severe stenosis controversies and promises] 159
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 156
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 147
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 146
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 144
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 144
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 144
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 142
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 142
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 140
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 140
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 138
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 136
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 135
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 135
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes 135
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 133
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 132
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 132
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 132
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 130
2021 ESC/EACTS Guidelines for the management of valvular heart disease 130
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 127
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 126
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 126
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 125
Antithrombotic Therapy in Patients with Chronic Kidney Disease 124
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 123
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 123
Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention 121
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 121
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 121
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 121
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 117
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 117
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 116
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 115
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 114
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 113
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 113
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 112
Targeting Inflammation After Acute Myocardial Infarction 112
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention 111
Atrial and ventricular function in thalassemic patients with supraventricular arrhythmias 110
PCSK9 inhibitors: current status and emerging frontiers in lipid control 110
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 110
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 109
Current Management of In-Stent Restenosis 108
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 108
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 108
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 107
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 107
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 106
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 106
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 106
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes 106
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 105
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 105
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 104
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 104
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time 103
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional study 102
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 102
Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel 102
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 102
The year in cardiology 2017: coronary interventions 102
Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics 102
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 102
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 101
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 101
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 101
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 101
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 101
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 101
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 101
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 101
Transcatheter aortic valve implantation in 2017: state of the art 101
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 100
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 100
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 99
Tailoring duration of DAPT with risk scores 99
Clinical implication of different plaque distribution patterns in distal left main coronary artery 99
Diabetes mellitus: the scary killer haunting silently 98
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 98
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 98
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 98
A review of polypills for the prevention of atherosclerotic cardiovascular disease 97
Spontaneous coronary artery dissection 97
Reply: plaque rupture in stable coronary artery disease 97
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 97
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents 96
Totale 12.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 0 0 0 0 0 0 226
2021/20223.753 493 578 11 50 617 12 557 99 330 5 83 918
2022/20235.175 544 67 40 349 671 984 9 813 1.430 34 172 62
2023/20242.391 125 494 111 191 100 372 50 104 17 79 472 276
2024/20258.365 96 1.244 605 325 1.997 674 153 360 706 965 448 792
2025/202618.600 1.039 914 3.395 1.185 3.132 3.248 2.714 460 898 727 630 258
Totale 46.627